Treatment | A sat | CCP | Resp | V cmax | J max | V TPU | CE |
---|---|---|---|---|---|---|---|
[μmol m–2 s-1] | |||||||
Control | 31.16 ± 3.61 cd1 | 30.00a | 18.30 ± 1.15c | 33.50 ± 2.82de | 140.00 ± 2.67e | 22.70 ± 1.67c | 0.04 ± 0.00c |
ABA | 27.57 ± 4.25d | 30.00a | 18.40 ± 1.29c | 33.50 ± 2.30de | 162.00 ± 2.81d | 28.20 ± 1.29b | 0.04 ± 0.00c |
High BR | 31.27 ± 2.56 cd | 30.00a | 17.20 ± 1.05 cd | 34.10 ± 2.64d | 191.00 ± 3.11c | 32.70 ± 1.87a | 0.04 ± 0.00c |
ABA + low BR | 32.06 ± 3.17c | 30.00a | 23.10 ± 2.00ab | 37.90 ± 2.71c | 199.00 ± 3.09c | 27.00 ± 1.48b | 0.07 ± 0.00b |
ABA + medium BR | 33.19 ± 3.89c | 30.00a | 24.60 ± 1.65a | 45.20 ± 2.35b | 237.00 ± 3.47b | 20.40 ± 1.95d | 0.13 ± 0.00ab |
ABA + high BR | 49.51 ± 4.06a | 30.00a | 25.20 ± 1.45a | 51.90 ± 2.88a | 262.00 ± 3.55a | 25.90 ± 1.55bc | 0.15 ± 0.00a |
High ABA + high BR | 41.93 ± 3.73b | 30.00a | 20.80 ± 1.82b | 51.10 ± 2.63a | 236.00 ± 3.17b | 32.80 ± 1.73a | 0.14 ± 0.00ab |